Running on Empty: Navigating the GLP-1 and GIP/GLP-1 Receptor Agonist Drug Shortage Kimmy Nguyen May 27, 2024 4 min read Updated: Oct 30, 2025 By Sydnie Twillmann, PharmD Glucagon-like peptide 1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have been making the headlines recently, for more reasons than one
SeekPeptides has compiled the research, the clinical guidelines, and the practical wisdom that experienced users have learned through thousands of injections
NOT EVERYONE IS BUILT THE SAME WAY We offer the following and so much more and we have recently added Cagrilintide and Sermorelin to our peptide lineup
Skaaby T, Husemoen LLN, Pisinger C, Jrgensen T, Thuesen BH, Fenger M, et al